Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective study.

Kazuhiro TakahashiNobuyoshi KosakaYushi SuharaJuria NakanoKentaro YoshiharaYuma GotoIbuki SadakaneYuhei KoikeYuji YataHirotaka SuzukiShiro KurawakiKeiichiro MiyajimaKosuke IwataniYu ImaiKeigo SakanakaMinoru NakazonoTakashi KurauchiSotaro KayanoHajime OnumaKoichi AikawaTakafumi YanagisawaKojiro TashiroShunsuke TsuzukiYusuke KoikeAkira FurutaJun MikiTakahiro Kimuranull null

Published in: Japanese journal of clinical oncology (2023)

Our study has suggested that neoadjuvant chemotherapy would be more effective in high-risk upper tract urothelial carcinoma patients compared with adjuvant chemotherapy.

Keyphrases

neoadjuvant chemotherapy
locally advanced
end stage renal disease
lymph node
rectal cancer
newly diagnosed
ejection fraction
chronic kidney disease
primary care
prognostic factors
peritoneal dialysis
radiation therapy
clinical trial
cross sectional
patient reported outcomes
early stage
quality improvement